Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
Public ClinicalTrials.gov record NCT00401726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Patient Outcomes With Education, Drug Therapy, and Support (POETS): A Multicenter, Open-label, Randomized Study to Evaluate Depressed Subjects Treated With Venlafaxine Extended-release vs. Venlafaxine Extended-release Plus the Dialogues Time to Talk Program in a Primary Care Setting
Study identification
- NCT ID
- NCT00401726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Enrollment
- 537 participants
Conditions and interventions
Conditions
Interventions
- Venlafaxine ER Drug
- Dialogues Time to Talk Program Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Not listed
- Completion
- Sep 30, 2007
- Last update posted
- Apr 22, 2012
2006 – 2007
United States locations
- U.S. sites
- 44
- U.S. states
- 25
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35216 | — |
| Not listed | Birmingham | Alabama | 35235 | — |
| Not listed | Mesa | Arizona | 85206 | — |
| Not listed | Little Rock | Arkansas | 72211 | — |
| Not listed | San Jose | California | 95128 | — |
| Not listed | Avon | Connecticut | 06001 | — |
| Not listed | Cromwell | Connecticut | 06416 | — |
| Not listed | Wilmington | Delaware | 19805 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Pinellas Park | Florida | 33781 | — |
| Not listed | Stuart | Florida | 34996 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Cartersville | Georgia | 30120 | — |
| Not listed | Rome | Georgia | 30165 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Newburgh | Indiana | 47630 | — |
| Not listed | Waterloo | Iowa | 50702 | — |
| Not listed | Metairie | Louisiana | 70006 | — |
| Not listed | Benzonia | Michigan | 49616 | — |
| Not listed | Interlochen | Michigan | 49643 | — |
| Not listed | Kalamazoo | Michigan | 49009 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | Omaha | Nebraska | 68134 | — |
| Not listed | Las Vegas | Nevada | 89146 | — |
| Not listed | Charlotte | North Carolina | 28209 | — |
| Not listed | Charlotte | North Carolina | 28262 | — |
| Not listed | Cincinnati | Ohio | 45236 | — |
| Not listed | Columbus | Ohio | 43212 | — |
| Not listed | Kettering | Ohio | 45429 | — |
| Not listed | Mason | Ohio | 45040 | — |
| Not listed | Mogadore | Ohio | 44260 | — |
| Not listed | Allentown | Pennsylvania | 18104 | — |
| Not listed | Newtown | Pennsylvania | 18940 | — |
| Not listed | Reading | Pennsylvania | 19606 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Anderson | South Carolina | 29621 | — |
| Not listed | Greer | South Carolina | 29651 | — |
| Not listed | Bristol | Tennessee | 37620 | — |
| Not listed | Dallas | Texas | 75235 | — |
| Not listed | Fort Worth | Texas | 76135 | — |
| Not listed | Plano | Texas | 75093 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Charleston | West Virginia | 25301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00401726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2012 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00401726 live on ClinicalTrials.gov.